[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100315776":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":44,"collaborators":19,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":19,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":19,"enrollmentInfo":56,"targetDuration":19,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":72,"overallStatus":79,"whyStopped":19,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"R3 Stem Cell","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Umbilical Allograft","EXPERIMENTAL","The study is nonrandomized with one arm. Depending on the body area being treated, the amount of the product utilized will be either 1.0cc's or 2cc's.",[13],"Other: Umbilical Allograft",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"OTHER","The umbilical allograft is regulated by the FDA and comes from a lab that is FDA registered.",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"David Greene, PhD, MBA","CONTACT","844-438-7836","dgreene@r3stemcell.com",[27],{"facility":28,"status":19,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Advanced Stem Cell Institute","Encino","California","91316","United States","US",{"type":35,"coordinates":36},"Point",[37,38],-118.50119,34.15917,{"lat":38,"lon":37},[41],{"name":42,"role":23,"phone":24,"phoneExt":19,"email":43},"David Greene, PhD","info@r3stemcell.com",{"type":45,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100315776","evaluation-of-outcomes-with-umbilical-cord-allograft-for-musculoskeletal-conditions-musculoskeletal-conditions-100315776",false,"NCT03390920","Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions","Evaluation of Regenerative Medicine Outcomes With Umbilical Allograft for Musculoskeletal Conditions","Inclusion Criteria:\n\n1. Age 18 and over.\n2. Ability to attend follow up visits or at least converse on phone or complete email follow up forms.\n\n4\\) Competent to understand the study protocol and provide voluntary informed consent.\n\nExclusion Criteria:\n\n1. Active Infection\n2. Pregnancy, Lactating\n3. Clotting disorder",true,"ALL","18 Years",{"count":57,"type":58},200,"ESTIMATED","INTERVENTIONAL",[61],"NA","The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.",[64,65,66,67,68,69,70,71],"Osteoarthritis","Tendinitis","Sports Injury","Degenerative Disc Disease","Degenerative Arthritis","Ligament Injury","Neuropathy","Pelvic Pain",[73,74,75,76,77,78],"regenerative medicine","arthritis","amniotic","stem cell","growth factor","cartilage","NOT_YET_RECRUITING","2021-09-10",{"date":82,"type":83},"2021-09-17","ACTUAL",{"date":85,"type":58},"2022-01-01",{"date":87,"type":58},"2030-01-01",{"name":5,"class":6},1]